Atovaquone oral suspension, USP is a yellow homogenous suspension containing 750 mg atovaquone USP per 5 mL.
18 cups x 5 mL (750 mg/ 5mL), NDC 0904-7064-25
42 cups x 5 mL (750 mg/ 5mL), NDC 0904-7064-53
Store at 15° to 25°C (59° to 77°F). Do not freeze. Dispense in tight container as defined in USP.
Instruct patients to:
• Ensure the prescribed dose of atovaquone oral suspension is taken as directed.
• Take their daily doses of atovaquone oral suspension with food, as food will significantly improve the absorption of the drug.
• Shake atovaquone oral suspension gently before use each time.
Camber Pharmaceuticals, Inc.
Piscataway, NJ 08854
HETERO LABS LIMITED 204961
Jeedimetla, Hyderabad – 500 055, India. Distributed By:
17177 N Laurel Park Dr., Suite 233
Livonia, MI 48152
Revised: June 2018
Atovaquone Oral Suspension, USP
|ATOVAQUONE atovaquone suspension|
|Labeler — Major Pharmaceuticals (191427277)|
Revised: 12/2020 Major Pharmaceuticals
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.